Characterization of early host responses in adults with dengue disease

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Tolfvenstam, Thomas ^a,b   Lindblom, Anna ^a   Schreiber, Mark J ^c   Ling, Ling ^a   Chow, Angelia ^d   Ooi, Eng E ^d   Hibberd, Martin L ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; DESMOSOME INTERMEDIATE JUNCTION COMPONENT PLAKOGLOBIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MICRORNA; MICRORNA 147; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; PLAKOGLOBIN; UNCLASSIFIED DRUG; CYTOKINE;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD ANALYSIS; BLOOD CELL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DEFERVESCENCE; DENGUE; DISEASE COURSE; FEMALE; GENE ACTIVATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; INNATE IMMUNITY; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SELF REPORT; SIGNAL TRANSDUCTION; DENGUE VIRUS; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOCYTE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ADAPTIVE IMMUNITY; ADULT; AGED; CYTOKINES; DENGUE; DENGUE VIRUS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; LEUKOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 79960890406     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-209     Document Type: Article

References (38)

1. Global burden of dengue. , http://www.pdvi.org
2. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005, 3:281-294. 10.1038/nrmicro1126, 15806094.
3. Katze MG, Fornek JL, Palermo RE, Walters KA, Korth MJ. Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat Rev Immunol 2008, 8:644-654. 10.1038/nri2377, 18654572.
4. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 2003, 77:11822-11832. 10.1128/JVI.77.21.11822-11832.2003, 229255, 14557666.
5. Nasirudeen AM, Liu DX. Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis. J Med Virol 2009, 81:1069-1081. 10.1002/jmv.21486, 19382257.
6. Conceicao TM, El-Bacha T, Villas-Boas CS, Coello G, Ramirez J, Montero-Lomeli M, Da Poian AT. Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J Infect 2009, 60:65-75.
7. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, Chin KC, Aw P, George J, Kuznetsov VA, Schreiber M, Vasudevan SG, Hibberd ML. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 2007, 1:e86. 10.1371/journal.pntd.0000086, 2100376, 18060089.
8. Becerra A, Warke RV, Martin K, Xhaja K, de Bosch N, Rothman AL, Bosch I. Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo. J Med Virol 2009, 81:1403-1411. 10.1002/jmv.21538, 2893327, 19551822.
9. Warke RV, Becerra A, Zawadzka A, Schmidt DJ, Martin KJ, Giaya K, Dinsmore JH, Woda M, Hendricks G, Levine T, Rothman AL, Bosch I. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. J Gen Virol 2008, 89:1605-1615. 10.1099/vir.0.2008/000968-0, 18559930.
10. Long HT, Hibberd ML, Hien TT, Dung NM, Van Ngoc T, Farrar J, Wills B, Simmons CP. Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. J Infect Dis 2009, 199:537-546. 10.1086/596507, 19138155.
11. Nascimento EJ, Braga-Neto U, Calzavara-Silva CE, Gomes AL, Abath FG, Brito CA, Cordeiro MT, Silva AM, Magalhaes C, Andrade R, Gil LH, Marques ET. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS One 2009, 4:e7892. 10.1371/journal.pone.0007892, 2775946, 19936257.
12. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, Dung NT, Long TH, Hoang DM, Chau NV, Thao le TT, Hien TT, Relman DA, Farrar J. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007, 195:1097-1107. 10.1086/512162, 17357045.
13. Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J Infect Dis 2008, 197:1459-1467. 10.1086/587699, 18444802.
14. Loke P, Hammond SN, Leung JM, Kim CC, Batra S, Rocha C, Balmaseda A, Harris E. Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis 2010, 4:e710. 10.1371/journal.pntd.0000710, 2886038, 20559541.
15. Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A. Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore 2006, 35:783-789.
16. Dengue: guidelines for diagnosis, treatment, prevention and control -- New edition. , http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf
17. Lye DC, Chan M, Lee VJ, Leo YS. Do young adults with uncomplicated dengue fever need hospitalisation? A retrospective analysis of clinical and laboratory features. Singapore Med J 2008, 49:476-479.
18. Ito M, Takasaki T, Yamada K, Nerome R, Tajima S, Kurane I. Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol 2004, 42:5935-5937. 10.1128/JCM.42.12.5935-5937.2004, 535301, 15583346.
19. Schreiber MJ, Holmes EC, Ong SH, Soh HS, Liu W, Tanner L, Aw PP, Tan HC, Ng LC, Leo YS, Low JG, Ong A, Ooi EE, Vasudevan SG, Hibberd ML. Genomic epidemiology of a dengue virus epidemic in urban Singapore. J Virol 2009, 83:4163-4173. 10.1128/JVI.02445-08, 2668455, 19211734.
20. Hoang LT, Lynn DJ, Henn M, Birren BW, Lennon NJ, Le PT, Duong KT, Nguyen TT, Mai LN, Farrar JJ, Hibberd ML, Simmons CP. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol 2010, 84:12982-12994. 10.1128/JVI.01224-10, 3004338, 20943967.
21. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
22. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
23. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC, Levin M, Kuijpers TW, Hibberd ML. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009, 5:e1000319. 10.1371/journal.pgen.1000319, 2607021, 19132087.
24. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, Libraty DH. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 2006, 177:7114-7121.
25. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388:621-625. 10.1016/j.bbrc.2009.08.062, 19686699.
26. Diamond MS. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J Interferon Cytokine Res 2009, 29:521-530. 10.1089/jir.2009.0069, 19694536.
27. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 2008, 82:609-616. 10.1128/JVI.01305-07, 2224571, 17977974.
28. Chang TH, Liao CL, Lin YL. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect 2006, 8:157-171. 10.1016/j.micinf.2005.06.014, 16182584.
29. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82:335-345. 10.1128/JVI.01080-07, 2224404, 17942531.
30. Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, Knoefel WT, Reed JC. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci USA 2009, 106:14524-14529. 10.1073/pnas.0907131106, 2732880, 19667203.
31. Huang W, Eum SY, Andras IE, Hennig B, Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 2009, 23:1596-1606. 10.1096/fj.08-121624, 2669424, 19141539.
32. Ogasawara N, Kojima T, Go M, Ohkuni T, Koizumi J, Kamekura R, Masaki T, Murata M, Tanaka S, Fuchimoto J, Himi T, Sawada N. PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells. Pharmacol Res 2010, 61:489-498. 10.1016/j.phrs.2010.03.002, 20227502.
33. Cardier JE, Rivas B, Romano E, Rothman AL, Perez-Perez C, Ochoa M, Caceres AM, Cardier M, Guevara N, Giovannetti R. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 2006, 13:335-340. 10.1080/10623320600972135, 17090406.
34. Prado-Montes de Oca E. Human beta-defensin 1: a restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol 2010, 42:800-804. 10.1016/j.biocel.2010.01.021, 20100591.
35. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, Lin YS, Yeh TM, Chen SH, Liu HS. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 2006, 87:3623-3630. 10.1099/vir.0.82093-0, 17098977.
36. Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci 2003, 116:4615-4628. 10.1242/jcs.00755, 14576355.
37. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, Abraham E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 2009, 106:15819-15824. 10.1073/pnas.0901216106, 2747202, 19721002.
38. Sierra B, Perez AB, Vogt K, Garcia G, Schmolke K, Aguirre E, Alvarez M, Volk HD, Guzman MG. MCP-1 and MIP-1alpha expression in a model resembling early immune response to dengue. Cytokine 2010, 52:175-183. 10.1016/j.cyto.2010.06.010, 20650649.